scholarly journals Calcineurin Activation Is Only One Calcium-dependent Step in Cytotoxic T Lymphocyte Granule Exocytosis

2007 ◽  
Vol 282 (25) ◽  
pp. 18009-18017 ◽  
Author(s):  
Michael J. Grybko ◽  
Jakub P. Bartnik ◽  
Georjeana A. Wurth ◽  
Arun T. Pores-Fernando ◽  
Adam Zweifach
2014 ◽  
Vol 20 (3) ◽  
pp. 359-371 ◽  
Author(s):  
Ziyan Zhao ◽  
Mark K. Haynes ◽  
Oleg Ursu ◽  
Bruce S. Edwards ◽  
Larry A. Sklar ◽  
...  

We screened the National Institutes of Health’s Molecular Libraries Small Molecule Repository for inhibitors of cytotoxic T lymphocyte (CTL) lytic granule exocytosis by measuring binding of an antibody in the extracellular solution to a lysosomal membrane protein (LAMP-1) that is transferred to the plasma membrane by exocytosis. We used TALL-104 human leukemic CTLs stimulated with soluble chemicals. Using high-throughput cluster cytometry to screen 364,202 compounds in a 1536-well plate format, we identified 2404 initial hits: 161 were confirmed on retesting, and dose–response measurements were performed. Seventy-five of those compounds were obtained, and 48 were confirmed active. Experiments were conducted to determine the molecular mechanism of action (MMOA) of the active compounds. Fifteen blocked increases in intracellular calcium >50%. Seven blocked phosphorylation of extracellular signal-regulated kinase (ERK) by upstream mitogen-activated protein kinase kinases >50%. One completely blocked the activity of the calcium-dependent phosphatase calcineurin. None blocked ERK catalytic activity. Eight blocked more than one pathway. For 8 compounds, we were unable to determine an MMOA. The activity of 1 of these compounds was confirmed from powder resupply. We conclude that a screen based on antibody binding to CTLs is a good means of identifying novel candidate immunosuppressants with either known or unknown MMOAs.


2006 ◽  
Vol 173 (1) ◽  
pp. 133-144 ◽  
Author(s):  
Nigel J. Waterhouse ◽  
Vivien R. Sutton ◽  
Karin A Sedelies ◽  
Annette Ciccone ◽  
Misty Jenkins ◽  
...  

Cytotoxic T lymphocyte (CTL)–induced death triggered by the granule exocytosis pathway involves the perforin-dependent delivery of granzymes to the target cell. Gene targeting has shown that perforin is essential for this process; however, CTL deficient in the key granzymes A and B maintain the ability to kill their targets by granule exocytosis. It is not clear how granzyme AB−/− CTLs kill their targets, although it has been proposed that this occurs through perforin-induced lysis. We found that purified granzyme B or CTLs from wild-type mice induced classic apoptotic cell death. Perforin-induced lysis was far more rapid and involved the formation of large plasma membrane protrusions. Cell death induced by granzyme AB−/− CTLs shared similar kinetics and morphological characteristics to apoptosis but followed a distinct series of molecular events. Therefore, CTLs from granzyme AB−/− mice induce target cell death by a unique mechanism that is distinct from both perforin lysis and apoptosis.


1998 ◽  
Vol 185 (2) ◽  
pp. 114-122 ◽  
Author(s):  
Koichi Kuwano ◽  
Akira Akashi ◽  
Sumio Arai

2016 ◽  
Vol 21 (6) ◽  
pp. 556-566 ◽  
Author(s):  
Ziyan Zhao ◽  
James A. deMayo ◽  
Ashley M. West ◽  
Marcy J. Balunas ◽  
Adam Zweifach

We previously developed an assay of cytotoxic T-lymphocyte lytic granule exocytosis based on externalization of LAMP-1/CD107A using nonphysiological stimuli to generate maximal levels of exocytosis. Here, we used polystyrene beads coated with anti-CD3 antibodies to stimulate cells. Light scatter let us distinguish cells that contacted beads from cells that had not, allowing comparison of signaling events and exocytosis from stimulated and unstimulated cells in one sample. Bead stimulation resulted in submaximal exocytosis, making it possible to detect compounds that either augment or inhibit lytic granule exocytosis. Coupled with the assay’s ability to distinguish responses in cells that have and have not contacted a stimulatory bead, it is possible to detect three kinds of compounds: inhibitors, stimulators, which cause exocytosis, and augmenters, which enhance receptor-stimulated exocytosis. To validate the assay, we screened a set of synthetic compounds identified using our previous assay and a library of 320 extracts prepared from tunicate-associated bacteria. One of the extracts augmented exocytosis threefold. Activity-guided fractionation and structure elucidation revealed that this compound is the known PKC activator teleocidin A-1. We conclude that our modified assay is suitable for screening synthetic compound plates and natural product collections, and will be useful for identifying immunologically active small molecules.


Immunity ◽  
2001 ◽  
Vol 15 (5) ◽  
pp. 847-859 ◽  
Author(s):  
Taras A. Lyubchenko ◽  
Georjeana A. Wurth ◽  
Adam Zweifach

Sign in / Sign up

Export Citation Format

Share Document